ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: And PTEN has been reported to be closely associated with the BCR‐ABL‐induced leukaemias in the treatment of Philadelphia chromosome‐positive leukaemia due to its role as a tumour suppressor in CML.22